Tinampay, Kilneth .

HRN: 08-33-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2023
CEFTRIAXONE 1G (VIAL)
09/23/2023
09/29/2023
IV
1.3gm
Q12
URTI, T/C Typhoid Fever
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: